Intarcia Gets Chance For AdComm Review Of ITCA 650; Hearing For Sotagliflozin Shot Down

 
• By Brenda Sandburg
Microphone
FDA advisory committe may consider Intarcia's drug implant application for treatment of type 2 diabetes • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers